Flexion Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Flexion Therapeutics Inc announces pricing of initial public offering
Flexion Therapeutics Inc:Says the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $13.00 per share.Shares are scheduled to begin trading on the NASDAQ Global Market under the ticker symbol FLXN on Feb. 12, 2014.Says it is offering all of the shares of common stock. Flexion has also granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock.Offering is expected to close on Feb. 18, 2014, subject to customary closing conditions.BMO Capital Markets and Wells Fargo Securities, LLC are acting as joint book-running managers.Needham & Company and Janney Montgomery Scott are acting as co-managers.
Latest Developments for Flexion Therapeutics Inc
Latest Key Developments in Biotechnology
- Tekmira Pharmaceuticals Corp announces proposed public offering of common stock
- La Jolla Pharmaceutical Co reports positive, top-line results from phase 2 clinical trial of gcs-100 in chronic kidney disease
- FDA designates Regado Biosciences Inc's REG1 in PCI as a fast track development program
- Omeros Corporation announces positive OMS721 Data in Serum from patients with aHUS
- Share this
- Digg this